Researchers conducted a multicenter trial that included acute ischemic stroke patients who were identified as having salvageable brain tissue through brain imaging software. The trial included 182 randomized patients at 38 centers across the U.S.
The study shows, in this select group of patients, thrombectomy improved outcomes. Forty-five percent of patients in the thrombectomy group were considered functionally independent 90 days after treatment, compared to just 17 percent who did not undergo a thrombectomy.
Additionally, the mortality rate was 14 percent in the thrombectomy group versus 26 percent in the control group.
“This landmark clinical trial showed that with careful patient and CT/MR imaging selection to identify brain tissue that was still salvageable beyond the traditional six-hour interventional window, up to 16 hours, mechanical thrombectomy was safe and effective in improving patients’ clinical outcomes,” said Sameer A. Ansari, MD, PhD, associate professor of radiology, neurology and neurological surgery at Chicago-based Northwestern’s Feinburg School of Medicine and a study co-author.
More articles on healthcare quality:
Survey: 44% of Americans self-diagnose online instead of visiting medical professional
Families less likely to prefer nursing home care for hospice patients, study finds
Stroke care quality for VA patients varies across facilities
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.